J&J Wins EU Approval for Subcutaneous Rybrevant Dosing Regimen

J&J Wins EU Approval for Subcutaneous Rybrevant Dosing RegimenSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com

J&J Wins EU Approval for Subcutaneous Rybrevant Dosing RegimenSource: Investing.com

Factbox-Stocks to watch as Trump’s new tariffs spell more uncertaintySource: Reuters

US Supreme Court to hear bid by oil companies to toss climate suitsSource: Reuters
TSX lower amid U.S. tariff uncertaintySource: Investing.com

Citigroup nears sale of 24% stake in Mexican retail bank - BloombergSource: Investing.com

AbbVie to invest $380 million to expand US manufacturing in IllinoisSource: Reuters

PayPal attracts takeover interest after stock slide, Bloomberg News reportsSource: Reuters

U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.12%Source: Investing.com
Norway stocks lower at close of trade; Oslo OBX down 0.40%Source: Investing.com

Ireland, Finland, others warn against relaxing EU merger rulesSource: Reuters